Smileyscope
Smileyscope is a medical-grade virtual reality digital therapeutics company that reduces procedural pain and anxiety in pediatric, women's health, and imaging settings. Its FDA Class II-cleared VR platform is deployed across hospitals in North America, Australia, the UK, and the Middle East.
- Company typePrivate
- Founded2017
- HeadquartersMelbourne, Australia
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Smileyscope does
Smileyscope is a Melbourne-founded, Austin-headquartered digital therapeutics company that has developed a medical-grade virtual reality platform to reduce procedural pain and anxiety in clinical settings. Its core technology combines proprietary antimicrobial, wipeable VR hardware (no controllers, touchscreen interface, offline operation without WiFi or Bluetooth) with clinical software built around a patented method called Procedural Choreography™, which reframes real-world sensations into supportive VR experiences synchronized to procedure timing. The platform spans three principal modes — Therapy Mode (FDA Class II cleared as a "Virtual Reality Analgesic"), Imaging Mode (MRI/CT simulation with graded exposure therapy reducing sedation needs by up to 92%), and a Mindfulness/Relaxation suite — and is supported by what the company describes as the largest randomized controlled trial in procedural VR (Chan et al, J Peds, 2019), demonstrating up to 60% pain reduction and 40% anxiety reduction. In 2025 the company extended the platform into women's health with the Lume product and into brain performance via the NeuroTrainer acquisition.
The company generates revenue through tiered multi-year subscription plans (Silver, Gold, Platinum) that bundle VR hardware, software licenses, training, warranties, and support on a 12-month minimum contract basis, with volume discounts for 5+ unit orders. Go-to-market is a hybrid enterprise field sales and inside sales motion targeting children's hospitals, NHS trusts, health systems, and specialty clinics across North America, Australia, the UK, and the Middle East, supplemented by clinical-evidence-led content marketing, conference presence, and reference-customer word of mouth. Customers include St. Jude, Harvard, King's College Hospital Dubai, Monash Children's, Nicklaus Children's, Perth Children's, Oxford University Hospital NHS, Chelsea and Westminster NHS, Rush Medical Center, and others, with adoption reaching 100% of Australian children's hospitals within 12 months of launch in 2022.
The company is operationally profitable in Australia and has raised approximately $10.7M in a 2025 funding round alongside a 2023 seed-prime round led by Breakthrough Victoria, Ten13, Alice Anderson Fund, and MedAngels. With 11-50 employees and FDA Class II, CE, TGA, and MHRA clearances across its primary markets, Smileyscope occupies a regulatory-first position in VR-based procedural analgesia with a defensible clinical evidence base and an expanding footprint across pediatric, women's health, imaging, and brain-performance applications.
Smileyscope firmographics
Firmographics- Name
- Smileyscope
- Legal name
- Smileyscope Holding Inc
- Website
- https://smileyscope.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Smileyscope is a medical-grade virtual reality digital therapeutics company that reduces procedural pain and anxiety in pediatric, women's health, and imaging settings. Its FDA Class II-cleared VR platform is deployed across hospitals in North America, Australia, the UK, and the Middle East.
- Ownership category
- akta.pro rank
Smileyscope industry classification
Industry- Product category
- Digital Therapeutics
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Services-Health Services (8000), Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Pediatrics & Adolescent Therapeutics (Digital) (HLACANAL)
- akta.pro secondary industries
- Women’s Health & Fertility Therapeutics (Digital) (HLACANAK), Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction) (EDAFAJAC)
Keywords
Where Smileyscope is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
Smileyscope business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- VR Hardware and Software Subscriptions: The company generates revenue primarily through tiered subscription plans (Silver, Gold, Platinum) that bundle medical-grade VR hardware with software licenses, training, warranties, and ongoing support. Plans require a 12-month minimum contract. Volume discounts are available for 5+ unit orders.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Silver: Entry-level plan for clinics and pathology centres with 4 specialized programs |
| Subscription | Multi-year contract | Gold: Comprehensive plan for hospitals with 50+ programs covering all departments |
| Subscription | Multi-year contract | Platinum: Enterprise tier with bespoke customization and white-labeling |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
Smileyscope product offering
Product offeringCore offering
Smileyscope develops and sells a medical-grade virtual reality (VR) digital therapeutics platform that reduces procedural pain and anxiety in healthcare settings. The platform pairs a proprietary antimicrobial, wipeable VR headset with FDA Class II cleared software, including Therapy Mode for pediatric needle procedures (60% pain reduction, 40% anxiety reduction), Imaging Mode for MRI/CT preparation (avoids sedation in up to 92% of cases), and the Lume sub-brand for women's health procedures. The product is sold to hospitals and clinics via tiered subscription plans (Silver, Gold, Platinum) bundling hardware, software, training, warranties, and support under multi-year contracts.
Product overview
Smileyscope is a digital therapeutics company offering a medical-grade virtual reality platform for healthcare settings. The core product is the Smileyscope VR Platform, which includes specialized modes for different applications: Therapy Mode (FDA-cleared for procedural pain/anxiety), Imaging Mode (for MRI/CT preparation), and Mindfulness and Relaxation. The company also offers a women's health sub-brand called Lume for obstetric and gynecological procedures. The product is delivered through tiered subscription plans (Silver, Gold, Platinum) that bundle medical-grade VR hardware, clinical programs, training, and support services.
Differentiator
Problem solved
Functional benefit
Brands
- Lume: Women's health VR product providing evidence-based anxiety and pain reduction for obstetric and gynecological procedures
Products and services
- Smileyscope VR Platform Medical-grade virtual reality platform that combines a proprietary antimicrobial, wipeable VR headset with touchscreen interface and FDA Class II cleared software to deliver evidence-based pain and anxiety reduction during medical procedures. Includes Therapy Mode (needle procedures), Imaging Mode (MRI/CT preparation), and a Mindfulness/Relaxation suite, with 50+ clinical-grade programs in 12 audio languages. Sold to hospitals and clinics via tiered subscription plans (Silver, Gold, Platinum) under multi-year contracts.
- Lume Sub-brand of the Smileyscope VR platform purpose-built for women's health applications, providing evidence-based anxiety and pain reduction for obstetric and gynecological procedures including IUD insertion, colposcopy, cervical biopsies, hysteroscopy, pregnancy loss management (MVA), labor and delivery (perineal suturing, epidural), fibroid treatment (Sonata), and sexual health examinations. Clinical evidence shows 89% of women report moderate or significant anxiety reduction and 96% would recommend Lume.
Quantifiable outcome
- Up to 60% reduction in procedural pain during pediatric needle procedures
- +11 more outcomes
Companies that use Smileyscope
Customer profileNamed customers16 records
Segments4 records
Ideal customer profiles4 records
Smileyscope technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Smileyscope partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core, flagship and minor.
- NeuroTrainercoreSmileyscope acquired NeuroTrainer to expand its capabilities in human brain performance. This acquisition enhances Smileyscope's evidence-based XR platform by integrating neuroperformance technologies, supporting expansion beyond procedural care into broader brain performance applications.
- King's College Hospital London, DubaiflagshipKing's College Hospital London, Dubai partnered with Smileyscope as a formal design partner guiding new product development across women's health, oncology, dialysis, and interventional radiology. The hospital has adopted Smileyscope as standard care across Emergency, PICU and pediatrics, and serves as a showcase for nurse-led digital innovation in the Middle East. The partnership includes expansion across multiple hospital sites.
- Melbourne Dental SchoolcoreMelbourne Dental School is running an MRFF (Medical Research Future Fund)-funded pilot research program evaluating Smileyscope in pediatric dentistry for children aged 3-5. The partnership involves adapting Smileyscope for dental procedures including compatibility with nitrous oxide use, and exploring adult dental applications and health economics research.
- Oxford University Hospital NHS Foundation Trust / Thinking of OscarminorOxford University Hospital NHS Foundation Trust, in partnership with Thinking of Oscar, uses Smileyscope during pediatric IV cannulation to reduce fear, pain and distress. This collaboration supports improved blood draws, IV management, and smoother experiences for patients, families and staff.
- Chelsea and Westminster Hospital NHSminorChelsea and Westminster Hospital NHS introduced Lume alongside local anesthetic and oral analgesia for outpatient hysteroscopy. Clinicians report improved patient confidence, reduced reliance on general anesthetic, and calmer, quicker procedures. The hospital serves as a reference site for Lume's women's health applications.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
Smileyscope competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key highlights7 records
Customer concentration
Smileyscope social profiles
Digital presenceSmileyscope compliance and trust
Trust signalCompliance4 records
Smileyscope financial estimates
Financial estimateRevenue estimate
Valuation estimate
Smileyscope leadership team
Management profileNumber of profiles
Profiles2 records
Smileyscope subsidiaries and ownership
Company hierarchySubsidiaries1 record
Smileyscope funding detail
Funding detailFunding overview
Funding rounds4 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Smileyscope M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Smileyscope
What does Smileyscope do?
Smileyscope develops and sells a medical-grade virtual reality (VR) digital therapeutics platform that reduces procedural pain and anxiety in healthcare settings. The platform pairs a proprietary antimicrobial, wipeable VR headset with FDA Class II cleared software, including Therapy Mode for pediatric needle procedures (60% pain reduction, 40% anxiety reduction), Imaging Mode for MRI/CT preparation (avoids sedation in up to 92% of cases), and the Lume sub-brand for women's health procedures. The product is sold to hospitals and clinics via tiered subscription plans (Silver, Gold, Platinum) bundling hardware, software, training, warranties, and support under multi-year contracts.
Is Smileyscope a public or private company?
Smileyscope is a private company. It is classified as venture growth investor backed and is currently operating.
When was Smileyscope founded?
Smileyscope was founded in 2017. It employs 11 to 50 people.
Where is Smileyscope based?
Smileyscope is headquartered in Melbourne, Australia, in the Oceania region.
How does Smileyscope make money?
One revenue line is on record: VR Hardware and Software Subscriptions.
Does Smileyscope have an API?
No public API is recorded for Smileyscope.
What industry is Smileyscope in?
Smileyscope's product category is Digital Therapeutics. Its primary akta.pro industry code is HLACANAL, Pediatrics & Adolescent Therapeutics (Digital), with a secondary code of HLACANAK, Women’s Health & Fertility Therapeutics (Digital). Its NAICS code is 339112 and its SIC code is 8000.